Cleared Traditional

K161840 - LINK SP-CL Hip System PoroLink (micropo...

K161840 is the FDA 510(k) clearance for LINK SP-CL Hip System PoroLink (micropo... by Waldemar Link GmbH & Co. KG. It is a Class 2 Orthopedic device (product code LZO) cleared through the Traditional 510(k) pathway after a 254-day FDA review.

K161840 · Waldemar Link GmbH & Co. KG · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2017
Decision
254d
Days
Class 2
Risk

K161840 is an FDA 510(k) clearance for the LINK® SP-CL® Hip System PoroLink® (microporous) and HX® (CaP) coated & LINK® .... Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Waldemar Link GmbH & Co. KG (Norderstedt, DE). The FDA issued a Cleared decision on March 16, 2017 after a review of 254 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Waldemar Link GmbH & Co. KG devices

Submission Details

510(k) Number K161840 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 05, 2016
Decision Date March 16, 2017
Days to Decision 254 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
132d slower than avg
Panel avg: 122d · This submission: 254d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 433
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K161840.
Locking Cage, Full XPE Cup
K163441 · United Orthopedic Corporation · Aug 2017
MiniMAX
K170845 · Medacta International S.A. · Aug 2017
AMIStem-H Proximal Coating
K161635 · Medacta International S.A. · Mar 2017
Revision Femoral Stem
K161226 · Lima Corporate S.P.A. · Feb 2017
Zimmer M/L Taper Hip Prosthesis
K161830 · Zimmer, Inc. · Oct 2016
Wagner SL Revision Stem Lateral, Wagner Cone Prosthesis® System
K161192 · Zimmer GmbH · Jul 2016